Search

Your search keyword '"Phenols (Class of compounds) -- Intellectual property"' showing total 328 results

Search Constraints

Start Over You searched for: Descriptor "Phenols (Class of compounds) -- Intellectual property" Remove constraint Descriptor: "Phenols (Class of compounds) -- Intellectual property"
328 results on '"Phenols (Class of compounds) -- Intellectual property"'

Search Results

1. Patent Issued for Combination of a PD-1 antagonist and a VEGFR/FGFR/RET tyrosine kinase inhibitor for treating cancer (USPTO 12083112)

2. 'Treatment For Tyrosine Degradation-Associated Disorders' in Patent Application Approval Process (USPTO 20240344072)

3. Researchers Submit Patent Application, 'Soluble Estradiol Capsule For Vaginal Insertion', for Approval (USPTO 20200352961)

4. Patent Application Titled 'Formulation With Cannabinoids' Published Online (USPTO 20200345816)

5. Researchers Submit Patent Application, 'Selective Estrogen Receptor Degraders', for Approval (USPTO 20200347073)

6. 'Selective Serotonin 2a/2c Receptor Inverse Agonists As Therapeutics For Neurodegenerative Diseases' in Patent Application Approval Process (USPTO 20200323836)

8. Patent Issued for Transdermal Delivery Of Cannabidiol With Other Active Moieties Including Cannabinoids (USPTO 10,799,545)

9. Patent Issued for Estrogen Combination For Treatment Of Multiple Sclerosis (USPTO 10,799,512)

10. 'Pharmaceutical Composition Comprising Fgfr Selective Tyrosine Kinase Inhibitor' in Patent Application Approval Process (USPTO 20200297711)

12. Researchers Submit Patent Application, 'Soluble Estradiol Capsule For Vaginal Insertion', for Approval (USPTO 20200276210)

13. Tiziana gets US patent on use of Milciclib in combo with tyrosine kinase inhibitors to treat HCC and other cancers

14. Researchers Submit Patent Application, 'Soluble Estradiol Capsule For Vaginal Insertion', for Approval (USPTO 20200230153)

15. Patent Application Titled 'Soluble Estradiol Capsule For Vaginal Insertion' Published Online (USPTO 20200230154)

16. Patent Application Titled 'Novel Salts Of Selective Estrogen Receptor Degraders' Published Online (USPTO 20200197375)

19. Patent Issued for Bruton'S Tyrosine Kinase Inhibitors (USPTO 10,662,187)

20. Patent Issued for Selective Estrogen Receptor Degraders (USPTO 10,654,866)

21. Patent Application Titled 'Multiphasic Contraceptive Regimen For Oral Combination Drug Formulation Of Progestin And Estrogen' Published Online (USPTO 20200147105)

22. Researchers Submit Patent Application, 'Tyrosine Kinase Inhibitors Regenerate Non-Cancerous Tissue After Cancer Therapy', for Approval (USPTO 20200138807)

23. 'Engineered Antibodies For The Detection Of Phosphorylated Tyrosine' in Patent Application Approval Process (USPTO 20200131277)

25. Patent Application Titled 'Composition For Cross Talk Between Estrogen Receptors And Cannabionoid Receptors' Published Online (USPTO 20200085978)

26. Patent Application Titled 'Tattoo Ink Containing Cannabis Or Hemp Derived Cannabinoids Or Mixture Of Both' Published Online (USPTO 20200069567)

27. Researchers Submit Patent Application, 'Immediate Release Formulations Of Cannabinoids', for Approval (USPTO 20200061022)

28. Researchers Submit Patent Application, 'Enzyme-Assisted Lipid-Based Extraction And Stabilization Of Phyto-Cannabinoids And Terpens And Products Obtained Thereof', for Approval (USPTO 20200061136)

29. Patent Issued for Multiphasic Contraceptive Regimen For Oral Combination Drug Formulation Of Progestin And Estrogen (USPTO 10,537,582)

30. Patent Issued for Molecules In The tryptophan-5-Hydroxytryptophan-Serotonin-NAS-Melatonin/6-Hydroxymelatonin Sulfate-Melatonin Receptor 1A Pathway In Neurological Diseases (USPTO 10,507,199)

31. Patent Issued for Detection Of Indazole Synthetic Cannabinoids (USPTO 10,509,046)

32. Patent Application Titled 'Imidazopyrazine Inhibitors Of Bruton'S Tyrosine Kinase' Published Online (USPTO 20190345164)

33. Patent Issued for Multiphasic Contraceptive Regimen For Oral Combination Drug Formulation Of Progestin And Estrogen (USPTO 10,463,678)

34. Patent Issued for Process For The Preparation Of A Sulfated Derivative Of 3,5-Diiodo-O-[3-Iodophenyl]-L-Tyrosine (USPTO 10,457,635)

36. Patent Application Titled 'Multiphasic Contraceptive Regimen For Oral Combination Drug Formulation Of Progestin And Estrogen' Published Online (USPTO 20190282587)

38. Patent Issued for Estrogen Receptor .Beta. Partial Agonist Having Estrogen Receptor .Alpha. Inhibitory Effect, And Gynecological Disease Therapeutic Agent Using Same (USPTO 10,369,159)

39. Patent Application Titled 'Vaginal Composition Comprising A Combination Of Estrogen And Vitamin D' Published Online (USPTO 20190224213)

40. Researchers Submit Patent Application, 'Use Of Cannabinoids In The Treatment Of Multiple Myeloma', for Approval (USPTO 20190175547)

42. Patent Application Titled 'Amidated Dopamine Neuron Stimulating Peptides For CNS Dopaminergic Upregulation' Published Online (USPTO 20190091284)

43. Patent Issued for Transdermal Drug Delivery Systems For Levonorgestrel And Ethinyl Estradiol (USPTO 10,231,977)

44. Patent Issued for Substituted Ethynyl Heterobicyclic Compounds As Tyrosine Kinase Inhibitors (USPTO 10,144,737)

45. Patent Issued for Estrogen Compositions for Vaginal Administration (USPTO 10016442)

46. Researchers Submit Patent Application, 'Adipate Forms and Compositions of Biaryl Inhibitors of Bruton'S Tyrosine Kinase', for Approval (USPTO 20180179189)

47. Patent Application Titled 'Phenyl-Piperazine Derivatives as Serotonin Reuptake Inhibitors' Published Online (USPTO 20180127389)

49. Patent Issued for 2-Substituted-5-Hydroxy-4H-Chromen-4-Ones as Novel Ligands for the Serotonin Receptor 2B (5-HT2B) (USPTO 9884836)

50. Researchers Submit Patent Application, 'Estrogen Ring Removal Tool', for Approval (USPTO 20170367877)

Catalog

Books, media, physical & digital resources